| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Microbio Co. Ltd (TWO: 4128)
4128 Technical Analysis
5
| As on 26th Nov 2025 4128 STOCK Price closed @ 20.85 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 26.72 & Strong Sell for SHORT-TERM with Stoploss of 33.76 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4128STOCK Price
| Open | 20.10 | Change | Price | % |
| High | 21.30 | 1 Day | 0.75 | 3.73 |
| Low | 20.10 | 1 Week | 1.05 | 5.30 |
| Close | 20.85 | 1 Month | -1.25 | -5.66 |
| Volume | 1981658 | 1 Year | -18.40 | -46.88 |
| 52 Week High 41.00 | 52 Week Low 18.95 | ||||
TWO Taiwan Most Active Stocks
| 5498 | 26.60 | -7.32% |
| 1815 | 77.10 | -1.78% |
| 4939 | 28.20 | -8.59% |
| 4979 | 208.00 | 2.46% |
| 3105 | 131.50 | -1.87% |
| 3163 | 276.50 | 9.94% |
| 6274 | 430.00 | 2.63% |
| 8074 | 35.50 | -4.57% |
| 8111 | 68.00 | 4.13% |
| 2641 | 21.00 | 4.74% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 4128 Daily Charts |
4128 Intraday Charts |
Whats New @ Bazaartrend |
4128 Free Analysis |
|
|
4128 Important Levels Intraday
| RESISTANCE | 23.16 |
| RESISTANCE | 22.42 |
| RESISTANCE | 21.96 |
| RESISTANCE | 21.50 |
| SUPPORT | 20.20 |
| SUPPORT | 19.74 |
| SUPPORT | 19.28 |
| SUPPORT | 18.54 |
4128 Forecast November 2025
| 4th UP Forecast | 32.7 |
| 3rd UP Forecast | 28.9 |
| 2nd UP Forecast | 26.55 |
| 1st UP Forecast | 24.2 |
| 1st DOWN Forecast | 17.5 |
| 2nd DOWN Forecast | 15.15 |
| 3rd DOWN Forecast | 12.8 |
| 4th DOWN Forecast | 9 |
4128 Weekly Forecast
| 4th UP Forecast | 30.87 |
| 3rd UP Forecast | 27.66 |
| 2nd UP Forecast | 25.67 |
| 1st UP Forecast | 23.68 |
| 1st DOWN Forecast | 18.02 |
| 2nd DOWN Forecast | 16.03 |
| 3rd DOWN Forecast | 14.04 |
| 4th DOWN Forecast | 10.83 |
4128 Forecast2025
| 4th UP Forecast | 65.27 |
| 3rd UP Forecast | 51.02 |
| 2nd UP Forecast | 42.22 |
| 1st UP Forecast | 33.41 |
| 1st DOWN Forecast | 8.29 |
| 2nd DOWN Forecast | -0.52 |
| 3rd DOWN Forecast | -9.32 |
| 4th DOWN Forecast | -23.57 |
Microbio Co. Ltd ( TWO Taiwan Symbol : 4128 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4128 Business Profile
Microbio Co., Ltd. develops and sells various therapeutics in Taiwan. It offers nutritional supplements, skin care products, and organic agricultural products. The company also provides MS-20 for ameliorating fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia and menstrual discomfort. Its pre-clinical stage products include SNS01, SNA02, and SNA-03 to treat various types of cancers, as well as SNA-07 for cancer immune therapy; and SNP-630 to treat non-alcoholic steatohepatitis. The company's Phase I clinical trial products consist of OB-318, an anti-cancer drug; MB-110 for the treatment of hepatitis C; SNP-810, an acetaminophen; FB317 to treat moderate-to-severe allergic asthma and chronic idiopathic urticaria; and FB704A for the treatment of rheumatoid arthritis, cancer, and cytokine storms. In addition, it offers FB825, which is in Phase II clinical trial for the treatment of atopic dermatitis, allergic asthma, hyper IgE syndrome, and food allergy. Additionally, the company's Phase III clinical trial products comprise ON101 to treat diabetic foot ulcer; and MB-6 that acts as an adjuvant for metastatic colorectal cancer. Further, the company's discovery stage pipeline includes FB121 for AIDS; SNA01 to treat PD-1 related cancer; SNA02 for cancer immune therapy; and SNS01 for recurrent metastatic non-small cell lung cancer. Microbio Co., Ltd. was founded in 2000 and is based in Taipei, Taiwan. Address: No.3,Yuan Qu Street, Taipei, Taiwan, 115
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service